{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:28:49Z","timestamp":1791300529115,"version":"4.1.0"},"reference-count":130,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1652,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1111\/j.1365-2990.2010.01153.x","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T08:49:46Z","timestamp":1292316586000},"page":"226-242","source":"Crossref","is-referenced-by-count":157,"title":["Review: An update on inflammatory and autoimmune myopathies"],"prefix":"10.1111","volume":"37","author":[{"given":"M. C.","family":"Dalakas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,22]]},"reference":[{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis, and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB3|cit3","first-page":"1335","volume-title":"Myology","author":"Engel","year":"2006"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/CBO9780511674747.026","volume-title":"Disorders of Voluntary Muscle","author":"Dalakas","year":"2010"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB5|cit5","first-page":"2696","volume-title":"Harrison's Principles of Internal Medicine","author":"Dalakas","year":"2008"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","article-title":"Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria","volume":"28","author":"Mastaglia","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coph.2010.03.001","article-title":"Inflammatory muscle diseases: a critical review on pathogenesis and therapies","volume":"10","author":"Dalakas","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1517\/17530051003713499","article-title":"Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies","volume":"4","author":"Schmidt","year":"2010","journal-title":"Expert Opin Med Diagn"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis - diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-2008-1041132","article-title":"Inclusion body myositis: new concepts","volume":"13","author":"Sekul","year":"1993","journal-title":"Semin Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-5728(97)00245-2","article-title":"HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies","volume":"84","author":"Koffman","year":"1988","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","article-title":"Dutch IBM Study Group. Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis","volume":"63","author":"Badrising","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nmd.2009.07.015","article-title":"Sporadic inclusion body myositis: HLA DRB1 allele interactions influence disease risk and clinical phenotype","volume":"19","author":"Mastaglia","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/120.4.653","article-title":"An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis: studies in 3 families","volume":"120","author":"Sivakumar","year":"1997","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB17|cit17","first-page":"527","article-title":"Pathology of the inflammatory myopathies","volume":"2","author":"Karpati","year":"1993","journal-title":"Baillieres Clin Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with upregulation of MHC-I associated with statin therapy","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1212\/WNL.43.6.1265-a","article-title":"Enhanced detection of Congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer disease using fluorescence technique","volume":"43","author":"Askanas","year":"1993","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0140-6736(92)90388-J","article-title":"b-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis","volume":"339","author":"Askanas","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1750-3639.2009.00290.x","article-title":"Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation","volume":"19","author":"Askanas","year":"2009","journal-title":"Brain Pathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00401-009-0564-6","article-title":"p62\/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis","volume":"118","author":"Nogalska","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0960-8966(96)00369-0","article-title":"Patterns of abnormal protein expression in target formations and unstructured cores","volume":"6","author":"De Bleecker","year":"1996","journal-title":"Neuromuscul Disord"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00401-003-0794-y","article-title":"Coexistence of X-linked recessive Emery-Dreifuss muscular dystrophy with inclusion body myositis-like morphology","volume":"104","author":"Fidzianska","year":"2004","journal-title":"Acta Neuropathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/brain\/awh052","article-title":"Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients","volume":"127","author":"Selcen","year":"2004","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnen\/63.5.484","article-title":"Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis","volume":"63","author":"Ferrer","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1750-3639.2005.tb00504.x","article-title":"Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and Inclusion Body Myositis","volume":"15","author":"Ferrer","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0046-8177(98)90425-7","article-title":"Rimmed vacuoles with b-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (post-poliomyelitis muscular atrophy): similarities with inclusion body myositis","volume":"29","author":"Semino-Mora","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","article-title":"TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia","volume":"79","author":"Weihl","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/mus.21471","article-title":"Nature of \u2018Tau\u2019 immunoreactivity in normal myonuclei and inclusion body myositis","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.21386","article-title":"Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","article-title":"Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM","volume":"70","author":"Chahin","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1172\/JCI38027","article-title":"Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease","volume":"119","author":"Goldfarb","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng718","article-title":"The UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy","volume":"29","author":"Eisenberg","year":"2001","journal-title":"Nat Genet"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0140","article-title":"Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.410230111","article-title":"Expression of immunoreactive major histocompatability complex products in human skeletal muscles","volume":"23","author":"Karpati","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0046-8177(89)90128-7","article-title":"Major histocompatibility complex class I antigen expression, immunologicalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies","volume":"20","author":"Emslie-Smith","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20833","article-title":"CAPN3 mutations in patients with idiopathic eosinophilic myositis","volume":"59","author":"Krahn","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410270402","article-title":"Microvascular changes in early and advanced dermatomyositis: a quantitative study","volume":"27","author":"Emslie-Smith","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI117520","article-title":"High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments","volume":"94","author":"Basta","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.410370709","article-title":"Immunopathogenesis of inflammatory myopathies","volume":"37","author":"Dalakas","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB43|cit43","first-page":"268","article-title":"Intercellular adhesion molecule-1 expression is upregulated in patients with dermatomyositis (DM)","volume":"34","author":"Stein","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-5728(95)00122-0","article-title":"Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne's dystrophy and non-weak controls","volume":"63","author":"Lundberg","year":"1995","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00005072-199603000-00009","article-title":"Cytokine expression profiles in idiopathic inflammatory myopathies","volume":"55","author":"Tews","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/jnen\/59.2.164","article-title":"Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies","volume":"59","author":"Confalonieri","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.58.12.1779","article-title":"Differential expression of chemokines in inflammatory myopathies","volume":"58","author":"De Bleecker","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.10462","article-title":"Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies","volume":"28","author":"Figarella-Branger","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.24977","article-title":"Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle","volume":"60","author":"Mammen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jnen\/60.9.847","article-title":"Cathepsins are upregulated by IFN-gamma\/STAT1 in human muscle culture: a possible active factor in dermatomyositis","volume":"60","author":"Gallardo","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.168.8.4154","article-title":"Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis","volume":"168","author":"Tezak","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awh518","article-title":"Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes","volume":"128","author":"Raju","year":"2005","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/clim.1999.4823","article-title":"Downregulation of TGF-\u03b21 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin","volume":"94","author":"Amemiya","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0140-6736(92)91134-T","article-title":"Viruses in the idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle","volume":"339","author":"Leff","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ana.410320215","article-title":"Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies","volume":"32","author":"Leon-Monzon","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibres invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.410230210","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. IV: cell-mediated cytotoxicity and muscle fiber necrosis","volume":"23","author":"Arahata","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ana.410160207","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis","volume":"16","author":"Engel","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0046-8177(86)80180-0","article-title":"Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies","volume":"17","author":"Engel","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0167-5699(94)90006-X","article-title":"The immunobiology of muscle","volume":"15","author":"Hohlfeld","year":"1994","journal-title":"Immunol Today"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2005.05.003","article-title":"Immunobiology of muscle: advances in understanding an immunological microenvironment","volume":"26","author":"Wiendl","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/awg114","article-title":"Muscle fibres and cultured muscle cells express the B7.1\/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies","volume":"126","author":"Wiendl","year":"2003","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/brain\/awh148","article-title":"Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity","volume":"127","author":"Schmidt","year":"2004","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.410390122","article-title":"Sporadic inclusion body myositis: counts of different types of abnormal fibers","volume":"39","author":"Pruitt","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0165-5728(03)00255-8","article-title":"Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study","volume":"142","author":"Confalonieri","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1172\/JCI118749","article-title":"Differential expression of perforin in muscle-infiltrating T cell in polymyositis and dermatomyositis","volume":"97","author":"Goebels","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410290509","article-title":"Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies","volume":"29","author":"Hohlfeld","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/brain\/120.6.929","article-title":"Cytotoxic mechanisms in inflammatory myopathies: co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells","volume":"120","author":"Behrens","year":"1997","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00005072-199612000-00003","article-title":"MHC class I mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis","volume":"55","author":"Schneider","year":"1996","journal-title":"J Neuropath Exp Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1212\/WNL.41.7.1128","article-title":"Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma","volume":"41","author":"Mantegazza","year":"1991","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/icb.1990.33","article-title":"Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon","volume":"68","author":"Bao","year":"1990","journal-title":"Immunol Cell Biol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB74|cit74","first-page":"503","article-title":"Induction of HLA-DR expression on human myoblasts with interferon-gamma","volume":"136","author":"Hohlfeld","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB75|cit75","first-page":"799","article-title":"Expression of major histocompatibility complex antigens on human myoblasts","volume":"23","author":"Roy","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-8966(98)00126-6","article-title":"Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies","volume":"9","author":"De Bleecker","year":"1999","journal-title":"Neuromusc Disord"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-5728(03)00218-2","article-title":"Expression of IFN-gamma-inducible chemokines in inclusion body myositis","volume":"141","author":"Raju","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.181.5.1863","article-title":"T cell receptor in polymyositis: clonal expansion of autoaggressive CD81 T cells","volume":"181","author":"Bender","year":"1995","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1172\/JCI116533","article-title":"Analysis of T cell receptor repertoire of muscle infiltrating T lymphocytes in polymyositis","volume":"91","author":"Mantegazza","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.152.5.2569","article-title":"Predominant TCR-alpha-beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies","volume":"152","author":"O'Hanlon","year":"1994","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.20293","article-title":"Long-term persistence of clonally expanded T cells in patients with polymyositis","volume":"56","author":"Benveniste","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-5728(97)00122-7","article-title":"Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis","volume":"79","author":"Fyhr","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0165-5728(97)00246-4","article-title":"T-cell heterogeneity in muscle lesions of inclusion body myositis","volume":"84","author":"Bender","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.4049\/jimmunol.167.7.4051","article-title":"Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis","volume":"167","author":"Nishio","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/brain\/123.10.2030","article-title":"Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies","volume":"123","author":"Amemiya","year":"2000","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1073\/pnas.0236183100","article-title":"Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis","volume":"100","author":"Hofbauer","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199103283241303","article-title":"Polymyositis mediated by T lymphocytes that express the gamma\/delta receptor","volume":"324","author":"Hohlfeld","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1084\/jem.176.6.1785","article-title":"Autoaggressive myocytotoxic T-lymphocytes expressing an unusual gamma delta T cell receptor","volume":"176","author":"Puschke","year":"1992","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4049\/jimmunol.169.1.515","article-title":"An autoreactive gamma delta TCR derived from a polymyositis lesion","volume":"169","author":"Wiendl","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9440(10)65141-3","article-title":"Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNA in inflammatory myopathies","volume":"155","author":"Murata","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/brain\/awn053","article-title":"Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle","volume":"131","author":"Schmidt","year":"2008","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1212\/WNL.54.1.65","article-title":"Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies","volume":"54","author":"Choi","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199407000-00008","article-title":"Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy","volume":"53","author":"De Bleecker","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.20649","article-title":"Myeloid dendritic cells in inclusion-body myositis and polymyositis","volume":"35","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0046-8177(86)80197-6","article-title":"Inclusion body myositis: a possible chronic persistent mumps myositis?","volume":"17","author":"Chou","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/01.wnl.0000192129.65677.87","article-title":"Inflammatory, immune, and viral aspects of inclusion-body myositis","volume":"66","author":"Dalakas","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.410250309","article-title":"Inclusion body myositis: the mumps virus hypothesis","volume":"25","author":"Nishino","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/WNL.36.4.569","article-title":"Polymyositis in an immunodeficiency disease in monkeys induced by a type D retrovirus","volume":"36","author":"Dalakas","year":"1986","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.256.17.2381","article-title":"Polymyositis in patients with AIDS","volume":"256","author":"Dalakas","year":"1986","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410230713","article-title":"Neuromuscular diseases associated with human immunodeficiency virus infection","volume":"23","author":"Dalakas","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(89)91793-5","article-title":"HTLV-1 and polymyositis in Jamaica","volume":"2","author":"Morgan","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ana.410290505","article-title":"Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis","volume":"29","author":"Illa","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB104|cit104","first-page":"132","article-title":"Interleukin-1 (IL-1) is toxic to human muscle","volume":"44","author":"Leon-Monzon","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/mus.880160411","article-title":"Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV-polymyositis","volume":"16","author":"Leon-Monzon","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/119.6.1887","article-title":"Inclusion body myositis in HIV-I and HTLV-I infected patients","volume":"19","author":"Cupler","year":"1996","journal-title":"Brain"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1086\/344315","article-title":"Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis","volume":"186","author":"Saito","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"10320","DOI":"10.1128\/JVI.78.19.10320-10327.2004","article-title":"Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia\/lymphoma virus type 1-infected patient with sporadic inclusion body myositis","volume":"78","author":"Ozden","year":"2004","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.21103","article-title":"IBM with HIV infection: 4 new cases withclonal expansion of viral-specific T cells","volume":"61","author":"Dalakas","year":"2007","journal-title":"Ann Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)62994-X","article-title":"Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers","volume":"167","author":"Fratta","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(01)06969-0","article-title":"Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis","volume":"358","author":"Vattemi","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ana.21115","article-title":"Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis","volume":"61","author":"L\u00fcnemann","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-59745-157-4_14","article-title":"Localization and MHC class II presentation of antigens targeted for macroautophagy","volume":"445","author":"Schmid","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.55.12.1509","article-title":"Molecular immunology and genetics of inflammatory muscle diseases","volume":"55","author":"Dalakas","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.21452","article-title":"Molecular links between inflamation and degeneration: lessons on \u2018Neuroinflammation\u2019 using IBM as a model","volume":"64","author":"Dalakas","year":"2008","journal-title":"Ann Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ana.21325","article-title":"Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta","volume":"64","author":"Kitazawa","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.54.5.1033","article-title":"AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis","volume":"54","author":"Banwell","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/jnnp.2009.174276","article-title":"Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid","volume":"80","author":"Muth","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","article-title":"Myopathy with antibodies to the signal recognition particle: clinical and pathological features","volume":"73","author":"Miller","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200 and 100 kDa proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christofer-Stine","year":"2010","journal-title":"Arthr Rheum"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB121|cit121","first-page":"692","article-title":"Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations","volume":"16","author":"Hengstman","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jnnp.2008.168294","article-title":"Toxic and drug-induced myopathies","volume":"80","author":"Dalakas","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2005.12.008","article-title":"Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future","volume":"16","author":"Dalakas","year":"2006","journal-title":"Neuromuscular Disord"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.10313","article-title":"Inflammatory Myopathies: clinical, diagnostic and therapeutic aspects","volume":"27","author":"Mastalgia","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.nmd.2007.11.001","article-title":"Sporadic inclusion body myositis: a continuing puzzle","volume":"18","author":"Needham","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","article-title":"The Efficacy of High Dose Intravenous Immunoglobulin (IVIg) in Patients With Inclusion-Body Myositis (IBM)","volume":"48","author":"Dalakas","year":"1997","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/mus.21377","article-title":"Dermatomyositis with inclusion body myositis pathology","volume":"40","author":"Layzer","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1365-2990.2010.01153.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","article-title":"Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis","volume":"132","author":"Dalakas","year":"2009","journal-title":"Brain"},{"issue":"1","key":"10.1111\/j.1365-2990.2010.01153.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2249.2009.04025.x","article-title":"Clinical applications of intravenous immunoglobulins in neurology","volume":"158","author":"Hughes","year":"2009","journal-title":"Clin Exp Immunol"}],"container-title":["Neuropathology and Applied Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2990.2010.01153.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2990.2010.01153.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T13:34:14Z","timestamp":1685885654000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2990.2010.01153.x"}},"subtitle":["Inflammatory myopathies"],"short-title":[],"issued":{"date-parts":[[2011,2,22]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01153.x","relation":{},"ISSN":["0305-1846"],"issn-type":[{"value":"0305-1846","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,22]]}}}